|
Gnanapragasam VJ, Payne H, Syndikus I, Kynaston H, Johnstone T |
Primary radical therapy selection in high-risk non-metastatic prostate canc... |
Wednesday, December 3, 2014 |
Clinical oncology (Royal College of Radiologists (Great Britain)) |
|
Spicer J, Baird R, Suder A, Cresti N, Corbacho JG, Hogarth L, et al. |
Phase 1 dose-escalation study of S-222611, an oral reversible dual tyrosine... |
Tuesday, December 2, 2014 |
European journal of cancer (Oxford, England : 1990) |
|
Crompton JG, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil RL, et al. |
Akt inhibition enhances expansion of potent tumor-specific lymphocytes with... |
Sunday, November 30, 2014 |
Cancer research |
|
Badreldin W, Krell J, Chowdhury S, Harland SJ, Mazhar D, Harding V, et al. |
The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed g... |
Saturday, November 29, 2014 |
BJU international |
|
Myint PK, Fox C, Kwok CS, Luben RN, Wareham NJ, Khaw KT |
Total anticholinergic burden and risk of mortality and cardiovascular disea... |
Saturday, November 29, 2014 |
Age and ageing |
|
Kilburn LB, Kocak M, Decker RL, Wetmore C, Chintagumpala M, Su J, et al. |
A phase 1 and pharmacokinetic study of enzastaurin in pediatric patients wi... |
Saturday, November 29, 2014 |
Neuro-oncology |
|
Clipson A, Wang M, de Leval L, Ashton-Key M, Wotherspoon A, Vassiliou G, et... |
KLF2 mutation is the most frequent somatic change in splenic marginal zone ... |
Friday, November 28, 2014 |
Leukemia |
|
Dolatshad H, Pellagatti A, Fernandez-Mercado M, Yip BH, Malcovati L, Attwoo... |
Disruption of SF3B1 results in deregulated expression and splicing of key g... |
Friday, November 28, 2014 |
Leukemia |
|
Ng FS, Calero-Nieto FJ, Gottgens B |
Shared transcription factors contribute to distinct cell fates |
Thursday, November 27, 2014 |
Transcription |
|
Ng FS, Calero-Nieto FJ, Gottgens B |
Shared transcription factors contribute to distinct cell fates |
Thursday, November 27, 2014 |
Transcription |
